欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0297/001
药品名称
CANIGEN DHPPi
活性成分
canine adenovirus 0.0 CCID50
canine distemper virus 0.0 CCID50
canine parainfluenza virus 0.0 CCID50
canine parvovirus 0.0 CCID50
剂型
Lyophilisate and Solvent
上市许可持有人
VIRBAC
参考成员国 - 产品名称
France (FR)
CANIGEN DHPPi
互认成员国 - 产品名称
Germany (DE)
Virbagen canis SHAPPi
Finland (FI)
Lithuania (LT)
Estonia (EE)
Canigen DHPPi
Hungary (HU)
Romania (RO)
Slovenia (SI)
Croatia (HR)
Cyprus (CY)
Slovakia (SK)
Czechia (CZ)
CANIGEN DHPPi lyofilizát a rozpouštědlo pro injekční suspenzi pro psy
Bulgaria (BG)
Latvia (LV)
Canigen DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem
Poland (PL)
Norway (NO)
Sweden (SE)
Greece (GR)
Italy (IT)
Portugal (PT)
Spain (ES)
CANIGEN DHPPi
Austria (AT)
Virbagen canis SHAPPi Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für H
Ireland (IE)
CANIGEN DHPPi
United Kingdom (Northern Ireland) (XI)
Canixin DHPPi
Luxembourg (LU)
Netherlands (NL)
Belgium (BE)
Canigen DHPPi
Denmark (DK)
许可日期
2016/05/25
最近更新日期
2023/10/09
药物ATC编码
QI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
14255_PuAR
Date of last change:2024/09/06
Final Product Information
|
SPC DHPPi clean_ End
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase